[Skip to Content]
[Skip to Content Landing]
Views 2,922
Citations 0
Health Agencies Update
January 29, 2019

Gene Therapy for Sickle Cell Disease Shows Promise

JAMA. 2019;321(4):334. doi:10.1001/jama.2018.21119

A National Institutes of Health (NIH) researcher recently presented preliminary findings of an ongoing multicenter, nationwide clinical trial of gene replacement therapy involving people with severe sickle cell disease. This trial was among several testing experimental sickle cell gene therapies for which preliminary findings were reported at the 60th annual American Society of Hematology meeting in San Diego.

×